UCB, a global biopharmaceutical company, today announced data from two clinical studies assessing ZLP-AI in adult patients who are anti-AChR antibody positivegMG as well as in healthy volunteers. The ...

If you conducted the anatomy of a fountain pen, Swedish illustrator Mattias Adolfsson believes you would find, from cap to ...

Patients in Kenya, currently paying up to Sh150,000 a month for the diabetes drug Ozempic, could soon access the treatment at ...

At Interpack 2026, IMA invites you on a journey through an entire pavilion in Hall 17 transformed into a living, breathing ...

MUMBAI – India is set to become the first major market to see a wave of generic semaglutide as patent protections for Novo Nordisk A/S’s weight-loss drugs expire March 27. At least a dozen major ...

By Ahmed Aboulenein WASHINGTON, April 13 (Reuters) - U.S. pharmacies are largely filling prescriptions for the abortion pill ...